Evicardio

Разработчик: Pixeloide

Описание

Evicardio was designed to provide the clinician and investigator with a database of more than 800 randomized clinical trials in cardiology, than may collaborate in the evidence base clinical practice.
The application includes four main tools
Clinical trials database
New data calculator
My trials (a personal database with new data)
Evidence based cardiology manual (only in Spanish)
1) Clinical trials database
The information may be consulted traditionally as abstracts, and more powerfully with two statistical "calculators":

a)Clinical trials events:
Evaluates drug/intervention trials with the parameters of evidence based medicine (EBM): statistical significance, absolute risk reduction (ARR), risk reduction (RR), relative risk reduction (RRR), number necessary to treat NNT, and odds ratio (OR);
b) Metaanalysis: to evaluate with the method of Mantel Hanszel Peto the main effect of series of clinical trials. Trials may be selected using 4 criteria of search (acronym, drug/intervention, therapeutic group, disease) and each event can be analyzed individually or in an overview grouping essays with similar designs. The analysis can be saved in your personal archive.
2) New data calculator
Evicardio allows you to enter new trials in your personal database, using this two calculators (events in a single trial, metaanalysis of many trials and a third for Diagnostic tests: to evaluate diagnostic methods (sensitivity, specificity, positive and negative predictive value, likelihood ratio, post test) and also gives you the chance to change the prevalence in order to estimate the probability in different risk populations. All the data can be saved and accede afterwards in your personal database.
3) My trials
You can keep in your file new information read from the papers, or add to previous metaanalysis new data.
Evicardio was developed by GEDIC. The original project leaders were Hernán Doval, Carlos Tajer y Juan Gagliardi. As coordinators of the work Susana Lipshitz, Javier Mariani and Maximiliano de Abreu. Cardiologists that help with the summaries: Adriana Acosta, Laura Antonietti, Aníbal Arias, Laura Arias, Rafael Feldman, Diego Funes, Javier Guetta, Luciano Lucas, Diego Manente, Walter Mason y Mariano Trevisan.
The computing-design and application was developed in collaboration with Pixeloide, Inc. As secretary we thank the huge help of Silvina Ruth Bravo.
EVICARDIO ® has copyright.
Скрыть Показать больше...

Скриншоты

Evicardio Частые Вопросы

  • Приложение Evicardio бесплатное?

    Да, Evicardio полностью бесплатное и не содержит встроенных покупок или подписок.

  • Является ли Evicardio фейковым или мошенническим?

    Недостаточно отзывов для надежной оценки. Приложению нужно больше отзывов пользователей.

    Спасибо за ваш голос

  • Сколько стоит Evicardio?

    Приложение Evicardio бесплатное.

  • Сколько зарабатывает Evicardio?

    Чтобы получить оценку дохода приложения Evicardio и другие данные AppStore, вы можете зарегистрироваться на платформе мобильной аналитики AppTail.

Оценки пользователей
Приложение еще не оценено в Новая Зеландия.
История оценок

Evicardio Отзывы Пользователей

Нет отзывов в Новая Зеландия
Приложение пока не имеет отзывов в Новая Зеландия.

Оценки

История позиций в топах
История рейтингов пока не доступна
Позиции в категории
Приложение еще не было в топах

Evicardio Установки

30дн.

Evicardio Доход

30дн.

Evicardio Доходы и Загрузки

Получите ценные инсайты о производительности Evicardio с помощью нашей аналитики.
Зарегистрируйтесь сейчас, чтобы получить доступ к статистика загрузок и доходов и многому другому.

Информация о приложении

Категория
Medical
Разработчик
Pixeloide
Языки
English
Последнее обновление
1.6 (8 лет назад )
Выпущено
Oct 20, 2013 (11 лет назад )
Также доступно в
Новая Зеландия
Обновлено
3 недели назад
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.